CompletedPhase 2NCT02503137

A Study of SM04554 Applied Topically to the Scalp of Male Subjects With Androgenetic Alopecia Analyzed by Biopsy of the Scalp Prior To and Post Dosing

Studying Alopecia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Biosplice Therapeutics, Inc.
Principal Investigator
Yusuf Yazici, M.D., MD
Biosplice Therapeutics, Inc.
Intervention
Topical SM04554 solution(drug)
Enrollment
49 enrolled
Eligibility
18-65 years · MALE
Timeline
20152016

Study locations (5)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02503137 on ClinicalTrials.gov

Other trials for Alopecia

Additional recruiting or active studies for the same condition.

See all trials for Alopecia

← Back to all trials